• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background.

作者信息

Bolli Alessandro, Di Domenico Paolo, Pastorino Roberta, Busby George B, Bottà Giordano

机构信息

Center for Genomic Medicine, Allelica, Rome, Italy (A.B., P.D.D., G. Bottà).

Department of Woman, Child, and Public Health, Gemelli University Hospital IRCCS, Rome, Italy (R.P.).

出版信息

Circulation. 2021 Apr 6;143(14):1452-1454. doi: 10.1161/CIRCULATIONAHA.120.051843. Epub 2021 Mar 8.

DOI:10.1161/CIRCULATIONAHA.120.051843
PMID:33677976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8021232/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d8d/8021232/c110d89e3b9a/cir-143-1452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d8d/8021232/c110d89e3b9a/cir-143-1452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d8d/8021232/c110d89e3b9a/cir-143-1452-g001.jpg

相似文献

1
Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background.低密度脂蛋白胆固醇所致冠状动脉疾病风险取决于多基因背景。
Circulation. 2021 Apr 6;143(14):1452-1454. doi: 10.1161/CIRCULATIONAHA.120.051843. Epub 2021 Mar 8.
2
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.在 ODYSSEY OUTCOMES 试验中，具有高全基因组多基因风险评分的冠心病患者可能从阿利西尤单抗治疗中获得更大的临床获益。
Circulation. 2020 Feb 25;141(8):624-636. doi: 10.1161/CIRCULATIONAHA.119.044434. Epub 2019 Nov 11.
3
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.多基因对单基因家族性高胆固醇血症患者低密度脂蛋白胆固醇水平和心血管风险的贡献。
Circ Genom Precis Med. 2020 Oct;13(5):515-523. doi: 10.1161/CIRCGEN.120.002919. Epub 2020 Aug 13.
4
Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis?氧化型或天然低密度脂蛋白胆固醇：在动脉粥样硬化形成中哪个更重要？
J Am Coll Cardiol. 2006 Sep 5;48(5):980-2. doi: 10.1016/j.jacc.2006.06.001. Epub 2006 Aug 17.
5
Effects of Low-density Lipoprotein Cholesterol on Coronary Artery Calcification Progression According to High-density Lipoprotein Cholesterol Levels.根据高密度脂蛋白胆固醇水平，低密度脂蛋白胆固醇对冠状动脉钙化进展的影响
Arch Med Res. 2017 Apr;48(3):284-291. doi: 10.1016/j.arcmed.2017.06.005.
6
Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications.
Am J Cardiol. 1990 Dec 18;66(21):7I-12I. doi: 10.1016/0002-9149(90)91257-7.
7
Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.脂蛋白(a)和低密度脂蛋白胆固醇升高可预测早发冠心病患者血管造影病变的严重程度和复杂性。
J Clin Lipidol. 2018 Jul-Aug;12(4):1019-1026. doi: 10.1016/j.jacl.2018.03.090. Epub 2018 Apr 3.
8
Wives of patients with acute myocardial infarction are at an increased risk of developing coronary artery disease.
J Cardiovasc Risk. 2002 Feb;9(1):49-52. doi: 10.1177/174182670200900107.
9
Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.低高密度脂蛋白胆固醇是低密度脂蛋白胆固醇得到最佳控制的稳定冠状动脉疾病糖尿病患者长期临床结局的一个残余危险因素。
Heart Vessels. 2014 Jan;29(1):35-41. doi: 10.1007/s00380-013-0330-5. Epub 2013 Mar 21.
10
Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease.小而密的低密度脂蛋白胆固醇是稳定型冠心病老年男性二级预防有前途的生物标志物。
Geriatr Gerontol Int. 2018 Jun;18(6):965-972. doi: 10.1111/ggi.13287. Epub 2018 Mar 7.

引用本文的文献

1
Meta-prediction of coronary artery disease risk.冠状动脉疾病风险的元预测
Nat Med. 2025 Apr 16. doi: 10.1038/s41591-025-03648-0.
2
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.心血管疾病预防中的精准医学：美国队列中多血统多基因风险评分的临床验证
Nutrients. 2025 Mar 6;17(5):926. doi: 10.3390/nu17050926.
3
Genetic Predisposition to Coronary Artery Disease: Evaluating Statin Therapy in Elder Populations From PROSPER.冠状动脉疾病的遗传易感性：评估PROSPER研究中老年人群的他汀类药物治疗

本文引用的文献

1
Making the Most of Clumping and Thresholding for Polygenic Scores.充分利用聚类和阈值处理多基因评分。
Am J Hum Genet. 2019 Dec 5;105(6):1213-1221. doi: 10.1016/j.ajhg.2019.11.001. Epub 2019 Nov 21.
2
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.在 ODYSSEY OUTCOMES 试验中，具有高全基因组多基因风险评分的冠心病患者可能从阿利西尤单抗治疗中获得更大的临床获益。
Circulation. 2020 Feb 25;141(8):624-636. doi: 10.1161/CIRCULATIONAHA.119.044434. Epub 2019 Nov 11.
3
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
JACC Adv. 2025 Jan 8;4(2):101535. doi: 10.1016/j.jacadv.2024.101535. eCollection 2025 Feb.
4
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据：美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
5
Blood Lipid Polygenic Risk Score Development and Application for Atherosclerosis Ultrasound Parameters.血脂多基因风险评分的开发及其在动脉粥样硬化超声参数中的应用
Biomedicines. 2024 Dec 10;12(12):2798. doi: 10.3390/biomedicines12122798.
6
Polygenic Risk Scores and Extreme Coronary Artery Calcium Phenotypes (CAC=0 and CAC≥1000) in Adults ≥75 Years Old: The ARIC Study.多基因风险评分与≥75 岁成年人的极重度冠状动脉钙表型（CAC=0 和 CAC≥1000）：ARIC 研究。
Circ Cardiovasc Imaging. 2024 Nov;17(11):e016377. doi: 10.1161/CIRCIMAGING.123.016377. Epub 2024 Nov 13.
7
An 8-SNP LDL Cholesterol Polygenic Score: Associations with Cardiovascular Risk Traits, Familial Hypercholesterolemia Phenotype, and Premature Coronary Heart Disease in Central Romania.一个包含 8 个单核苷酸多态性的 LDL 胆固醇多基因评分：与心血管风险特征、家族性高胆固醇血症表型和罗马尼亚中部的早发性冠心病的相关性。
Int J Mol Sci. 2024 Sep 18;25(18):10038. doi: 10.3390/ijms251810038.
8
Comparison between the Friedewald, Martin and Sampson Equations and LDL-C Quantification by Ultracentrifugation in a Mexican Population.墨西哥人群中Friedewald、Martin和Sampson方程与通过超速离心法进行低密度脂蛋白胆固醇（LDL-C）定量分析的比较。
Diagnostics (Basel). 2024 Jun 13;14(12):1241. doi: 10.3390/diagnostics14121241.
9
Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - A system dynamics model.多基因风险评分用于冠心病一级预防的健康经济分析——一个系统动力学模型
Am J Prev Cardiol. 2024 May 18;18:100672. doi: 10.1016/j.ajpc.2024.100672. eCollection 2024 Jun.
10
Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.冠状动脉疾病多基因风险评分对冠状动脉疾病临床风险因素的修正。
Med. 2024 May 10;5(5):459-468.e3. doi: 10.1016/j.medj.2024.02.015. Epub 2024 Apr 19.
对 480,000 名成年人的冠心病的基因组风险预测：对一级预防的影响。
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893. doi: 10.1016/j.jacc.2018.07.079.
4
The UK Biobank resource with deep phenotyping and genomic data.英国生物银行资源库，具有深度表型和基因组数据。
Nature. 2018 Oct;562(7726):203-209. doi: 10.1038/s41586-018-0579-z. Epub 2018 Oct 10.
5
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.全基因组多基因疾病风险评分可识别出与单基因突变风险相当的个体。
Nat Genet. 2018 Sep;50(9):1219-1224. doi: 10.1038/s41588-018-0183-z. Epub 2018 Aug 13.